Fayez Sarofim & Co
BSX icon

Fayez Sarofim & Co’s Boston Scientific BSX Stock Holding History

Fayez Sarofim & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,369
Closed -$337K – 303
2026
Q1 		$337K Buy
5,369
+42
+0.8% +$3.36K ﹤0.01% 253
2025
Q4 		$508K Hold
5,327
– – ﹤0.01% 228
2025
Q3 		$520K Buy
5,327
+111
+2% +$11.5K ﹤0.01% 233
2025
Q2 		$560K Sell
5,216
-425
-8% -$43K ﹤0.01% 223
2025
Q1 		$569K Buy
5,641
+290
+5% +$29.2K ﹤0.01% 223
2024
Q4 		$478K Buy
5,351
+1,558
+41% +$137K ﹤0.01% 234
2024
Q3 		$318K Sell
3,793
-8,926
-70% -$704K ﹤0.01% 252
2024
Q2 		$979K Sell
12,719
-7
-0.1% -$512 ﹤0.01% 172
2024
Q1 		$872K Buy
12,726
+7
+0.1% +$450 ﹤0.01% 175
2023
Q4 		$833K Sell
12,719
-1,324
-9% -$70.7K ﹤0.01% 176
2023
Q3 		$741K Buy
14,043
+8,935
+175% +$469K ﹤0.01% 180
2023
Q2 		$276K Buy
+5,108
New +$267K ﹤0.01% 252

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fayez Sarofim & Co's BSX Position: Q2 2026 in Review

Fayez Sarofim & Co sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 5,369 shares — an estimated $337K sold.

Fayez Sarofim & Co first reported a position in BSX in Q2 2023 and held it in 12 quarters. The position peaked at $979K in Q2 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fayez Sarofim & Co reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Fayez Sarofim & Co sold 5,369 Boston Scientific shares in Q2 2026, an estimated $337K.
  • Fayez Sarofim & Co first reported a position in Boston Scientific in Q2 2023 and held it in 12 quarters.
  • Fayez Sarofim & Co's Boston Scientific position peaked at $979K in Q2 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fayez Sarofim & Co's 13F filing for Q2 2026, filed 17 Aug 2026.